Synthesis and secretion of transforming growth factor beta isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen

British Journal of Cancer

Volumn 74, Issue 3, 1996, Pages 352-358

  Benson, J R ^a   Wakefield, L M ^b   Baum, M ^a   Colletta, A A ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Growth factor; Paracrine mechanism; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ARTICLE; BREAST TUMOR; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REPORTER GENE;

EID: 0030036145     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.365     Document Type: Article

References (37)

1. ACLAND P, DIXON M, PETERS G AND DICKSON C. (1990). Subcellular fate of the Int-2 oncoprotein is determined by choice of initiation codon. Nature, 343, 662-665.
2. ADAMS EF, NEWTON CJ, BRAUNSBERG H, SHAIKH N, GHILCHIK M AND JAMES VHT. (1988). Effects of human breast fibroblasts on growth and 17β oestradiol dehydrogenase activity of MCF-7 cells in culture. Breast Cancer Res. Treat., 11, 165-172.
3. ARRIK BA, GRENDELL RL AND GRIFFIN LA. (1994). Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells. Mol. Cell. Biol., 14, 619-628.
4. BENSON JR AND BAUM M. (1993). Breast cancer, desmoid tumours and familial adenomatous polyposis - a unifying hypothesis. Lancet, 342, 848-850.
5. BENSON JR AND BAUM M. (1996). Tamoxifen-induced transforming growth factor β1 expression in human breast cancer cells (letter to the Editor). Br. J. Cancer, (in press).
6. BROOKES MD, EBBS SR, COLLETTA AA AND BAUM M. (1992). Desmoids treated with triphenylethylenes. Eur. J. Cancer, 28, 1014-1018.
7. 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res., 52, 4261-4264.
8. COLLETTA AA, WAKEFIELD LM, HOWELL FV, ROOZENDAAL KEP, DANIELPOUR D, EBBS SR, SPORN MB AND BAUM M. (1990). Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br. J. Cancer, 62, 405-409.
9. CROSS M AND DEXTER TM. (1991). Growth factors in development, transformation and tumorigenesis. Cell, 64, 271-280.
10. CUNHA GR AND DONJACOUR A. (1987). Stromal-epithelial interactions in normal and abnormal prostatic development. Prog. Clin. Biol. Res., 239, 251-272.
11. DANIELPOUR D, DART LL, FLANDERS KC, ROBERTS AB AND SPORN M. (1989). Immunodetection and quantitation of the two forms of transforming growth factor β secreted by cells in culture. J. Cell Physiol., 138, 79-86.
12. DERYNCK R, JARRETT JA, ELLSON YC, EATON DH, BELL JR, ASSOIAN RK, ROBERTS AB, SPORN M AND GOEDDELL DV. (1985). Human transforming growth factor beta complementary DNA sequence and expression in normal and transformed cells. Nature, 316, 701-705.
13. EARLY BREAST CANCER TRIALISTS COLLABORATIVE GROUP. (1992). Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet, 339, 1-15 and 71-75.
14. FLANDERS KC, THOMPSON NL, CISSEL DS, VAN OBBERGEHN-SCHILLING E et al. (1989). Transforming growth factor β histochemical localisation with antibodies to different epilopes. J. Cell. Biol., 108, 653 660.
15. FRESHNEY RI. (1987). Culture of Animal Cells a Manual of Basic Technique. Alan Liss: New York.
16. GREEN S AND LEAKE R. (1987). Steroid Hormones a Practical Approach. Green B and Leake R (eds). IRL Press: CJxford.
17. GREEN S, WALTER P, KUMAR V, KRUST A, BORNERT J-M. ARGOS P AND CHAMBON P. (1986). Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature, 320, 137 139.
18. HAGGIE JA, SELLWOOD RA, HOWELL A, BIRCH JM AND SHOR SL. (1987). Fibroblasts from relatives of patients with hereditary breast cancer show foetal-like behaviour vitro. Lancet, 1, 1455 1457.
19. JOHNSON LK, VLODAVSKY I, BAXTER JD AND GOSPODAROWICZ D. (1980). Nuclear accumulation of epidermal growth factor in cultured rat pituitary cells. Nature, 287, 340 343.
20. KNABBE C, LIPPMAN ME, WAKEFIELD LM, FLANDERS KC, KASID A, DERYNCK R AND DICKSON RB. (1987). Evidence that transforming growth factor beta is a hormonally regulated negative growth factor in human breast cancer. Cell, 48, 417 428.
21. KUMAR V AND CHAMBON P. (1988). The oestrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell, 55, 145 156.
22. MEDICAL RESEARCH COUNCIL SCOTTISH TRIALS OFFICE. (1987). Adjuvant tamoxifen in the management of operable breast cancer. Lancet, 2, 171 175.
23. MUIR G, BUTTA A, SHEARER RJ, FISHER C, DEARNLEY DP, FLANDERS KC, SPORN MB AND COLLETTA AA. (1994). Induction of TGF β in hormonally treated human prostate cancer. Br. J. Cancer, 69, 130 134.
24. NEUMANN JR, MORENCY CA AND RUSSIAN KO. (1987). A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques, 5, 444.
25. NOLVADEX ADJUVANT TRIAL ORGANISATION. (1988). Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. Br. J. Cancer, 57, 608 612.
26. MACCALLUM J, BARTLETT JMS, THOMPSON AM, KEEN JC, DIXON JM AND MILLER WB. (1994). Expression of transforming growth factor β mRNA isoforms in human breast cancer. Br. J. Cancer, 69, 1006 1009.
27. PERRY RR, KANG Y AND GREAVES BR. (1995). Relationship between tamoxifen-induced transforming growth factor β1 expression, cytostasis and apoptosis in human breast cancer cells. Br. J. Cancer, 72, 1441 1446.
28. PETERSON DW, HOYER PE AND VAN DEURS B. (1987). Frequency and distribution of oestrogen receptor positive cells in normal non-lactating human breast tissue. Cancer Res., 47, 5748 5751.
29. ROBERTS AB, ANZANO MA, LAMB LC, SMITH JM AND SPORN MB. (1981). New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc. Natl Acad. Sci. USA, 78, 5339 5343.
30. ROBERTS AB, ANZANO MA, WAKEFIELD LM, ROCHE NS, STERN DF AND SPORN MB. (1985). Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl Acad. Sci. USA, 82, 119 123.
31. ROBERTS AB, FLANDERS KC, KONDAIAH P, THOMPSON NL, VAN OBBERGEHN-SCHILLING E, WAKEFIELD L, ROSSI P, DE CROMBRUGGE B, HEINE E AND SPORN MB. (1988). Transforming growth factor β biochemistry and roles in embryogenesis, tissue repair and remodelling, and carcinogenesis. Rec. Prog. Horm. Res., 44, 157 197.
32. SAMBROOK J, FRITSCH EF AND MANIATIS T. (1989). Molecular Cloning a Laboratory manual, 2nd ed. Cold Spring Harbor Press: Cold Spring Harbor, NY.
33. SCHOLL SM AND POUILLART P. Is CSF-1 a key mediator in breast cancer invasion and metastasis? The Lancet Conference, Brugge, April 1994.
34. SPENCE AM, SHEPPARD PC, DAVIE R, MATUO Y, NISHI N, MCKEEHAN WL, DODD JG AND MATUSIK RJ, (1989). Regulation of a bifunctional mRNA results in synthesis of secreted and nuclear probasin. Proc. Natl Acad. Sci. USA, 86, 7843 7847.
35. TERENIUS L. (1968). Two modes of interaction between oestrogen and anti-oestrogen. Acta Endocrinol., 64, 47 58.
36. 125I-labelled type β transforming growth factor from human platelets. Proc. Natl Acad. Sci. USA, 81, 6757 6761.
37. YEH H-J, PIERCE GF AND DEUEL TF. (1987). Ultrastructural localisation of platelet-derived growth factor/v-sis related protein(s) in cytoplasm and nucleus of simian sarcoma virus-transformed cells. Proc. Natl Acad. Sci. USA, 84, 2317 2321.